Verastem Oncology (VSTM) Misses Q1 EPS by 43c
Verastem Oncology (NASDAQ: VSTM) reported Q1 EPS of ($0.43). Revenue for the quarter came in at $18.67 million.
For earnings history and earnings-related data on Verastem Oncology (VSTM) click here.
Verastem Oncology (NASDAQ: VSTM) reported Q1 EPS of ($0.43). Revenue for the quarter came in at $18.67 million.
For earnings history and earnings-related data on Verastem Oncology (VSTM) click here.